Recent Generic Launches
Several new generics have launched in the United States, including for the migraine therapy Zomig, the anticancer therapy Doxil, and an anti-inflammatory used to treat respiratory conditions associated with COVID-19.
Padagis Launches Generics of Zomig, Doxil
Padagis has launched a generic version of Zomig (zolmitriptan) Nasal Spray, which is used to treat adults and adolescents with migraine headaches with or without aura. The company has also launched a generic version of the anticancer agent Doxil (doxorubicin liposome injection) through its partnership with Ayana Pharma. Doxil is an anthracycline topoisomerase inhibitor that is used to treat patients with ovarian cancer, AIDS-related Kaposi’s sarcoma and multiple myeloma.
These are the company’s first launches since it separated from Perrigo in July 2021.
Amneal Launches Generic of Decadron
Amneal Pharmaceuticals has launched a generic version of Decadron, an anti-inflammatory glucocorticoid steroid used to treat several medical conditions, including respiratory complications associated with COVID-19.
Additionally the FDA has approved Amneal Pharmaceuticals’ abbreviated new drug application for difluprednate ophthalmic emulsion a generic version of Durezol and is used in the treatment of inflammation and pain associated with ocular surgery.
Endo Launches Generic of Miacalcin for Osteoporosis
Endo International’s Par Sterile Products business has begun shipping calcitonin salmon injection, a generic of Viatris’ Miacalcin, for the treatment of patients with hypercalcemic emergencies. It is also used for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause and to treat symptomatic Paget’s disease of bone.
It is offered in multi-dose vials (2 mL), and is manufactured in a U.S. facility in Rochester, Michigan.
Dr. Reddy’s Launches Generic of Akovaz
Dr. Reddy’s has launched Ephedrine Sulfate Injection 50 mg/mL, a therapeutic equivalent generic version of Exela Pharma’s Akovaz, which treats low blood pressure.
The product, which is a clear, colorless, sterile solution for intravenous injection and supplied as a 1 mL fill in a 2 mL clear glass single-dose vial with purple flip-off cap.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
August 3rd 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
FDA Extends Review of Blenrep Combinations in Multiple Myeloma
August 3rd 2025Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing and tolerability. The new action date is Oct. 23, 2025.
Read More
